Rituximab and dose dense chemotherapy in primary breast lymphoma

Haematologica

Volumn 92, Issue 8, 2007, Pages 1147-1148

  Avilés, Agustin ^a,b   Castañeda, Claudia ^a   Neri, Natividad ^a   Cleto, Sergio ^a   Nambo, M Jesús ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Chemotherapy; Primary breast lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BREAST LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; COMPARATIVE STUDY; DRUG EFFICACY; FEBRILE NEUTROPENIA; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; OVERALL SURVIVAL; PROGNOSIS; STATISTICAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; AGED; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HEMATOLOGIC DISEASE; IMMUNOTHERAPY; LETTER; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HUMANS; IMMUNOTHERAPY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDNISONE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 35748930913     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10892     Document Type: Article

References (10)

1. Barista I, Baltali E, Tekuzman G, Kars A, Ruacan S, Özisik Y, et al. Primary breast lymphoma. Acta Oncol 2000;39:135-9.
2. Lyons JA, Myles J, Pohlman B, Macklis RM, Crowe J, Crownover RL. Treatment and prognosis of primary breast lymphoma. Am J Clin Oncol 2000;23:334-6.
3. Ribrag V, Bibeau F, Weshi AE, Frayfer J, Fadel C, Cebotaru C, et al. Primary breast lymphoma. A report of 20 cases. Br J Haematol 2001;115:253-6.
4. Cabras MG, Amichetti M, Nagliati M, Orrú P, Mamusa AM, Angelucci E. Primary non-Hodgkin's lymphoma of the breast. Haematologica 2004;89:1527-8.
5. Kuper-Hommel MJJ, Snijder S, Janssen-Heijnen MLG, Vrints LW, Kluin-Nelemans JC, Coebergh JWW, et al. Treatment and survival of 38 female breast lymphoma. Ann Hematol 2003;82:397-404.
6. Wong WM, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin's of the breast. The Mayo Clinic experience. J Surg Oncol 2002;80:19-25.
7. Duncan UE, Reddy WB, Jhala NC, Chhieng AC, Jhala DN. Non-Hodgkin's lymphoma of the breast. Ann Diag Pathol 2006;10:144-8.
8. Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CA. Primary breast lymphoma. A pooled analysis of prognostic factors and survival in 93 cases. Ann Saud Med 200525:288-93.
9. Avilés A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S.: Primary breast lymphoma. Results of a controlled clinical trial. Oncology 2005;69:256-60.
10. McMillan A, Central nervous system. Directed preventive therapy in adults with lymphoma. Br J Haematol 2005;131:13-21.